Signing-of-MoU-at-US-Kenya-Business-Forum-held-in-Washington-DC
Under the umbrella of RVL Healthcare Ltd, Redhill Cancer Hospital and Siemens Healthineers have partnered to build a Cancer Center and Research Park in Nairobi, Kenya.
The two parties signed a Memorandum of Understanding during the recent US-Kenya Business Forum held in Washington, D.C.
According to a statement released by Siemens Healthineers on July 2nd,2024, the Construction of the facility will begin in August and be opened by the end of 2025.
“Our vision is to build Africa’s most comprehensive Cancer Center and Research Park focused on offering high-quality diagnosis services, cancer treatment, and groundbreaking research. As an institution, our mission is to provide affordable cancer services to our people and people in Africa, “commented Dr. Leela Prasad Pamidimukkala Founder and CEO of RVL Healthcare Ltd.
There are rising cancer cases globally, especially in Africa. Kenya alone accounts for 45,000 new cancer diagnoses and almost thirty-thousand cancer-related deaths per year (Global Cancer Observatory).
Through the integrated approach, the understanding will provide a one-stop solution for patients from across the region.
With a bold aim of conducting up to 200,000 cancer screenings and 4,000 surgeries per year, the facility will be fitted with state-of-the-art equipment along the entire Oncology pathway.
Siemens Healthineers will also support the healthcare facility with capacity-building programs, from physical training to remote engagements and AI-based services.
“By joining forces to build this unique Cancer Center and Research Park, we will be one step closer to realizing the vision of making essential cancer care more accessible. This ties into our company’s purpose of making healthcare more affordable and accessible for everyone, everywhere,” said Vivek Kanade, Managing Director of Siemens Healthineers, Middle East & Africa.
For the Research Park, which will be directly linked to the hospital, the two parties will collaborate with educational institutions and pharmaceutical companies for education programs.
The programs will increase skilled healthcare professionals in Africa further helping to elevate the local healthcare infrastructure.
“We are on a journey of reshaping Africa’s oncology landscape by using modern technologies and innovative solutions to provide affordable cancer care for the wider region. At the same time, we will be making a significant contribution to achieving Kenya’s goals for Universal Health Care,” emphasized Dr. Pamidimukkala.
The approach will also reduce the number of people traveling abroad for treatment, consequently supporting the local economy.
Also present at the signing was His Excellency Dr. William Samoei Ruto, President of Kenya, and Ambassador Meg Whitman, United States Ambassador to Kenya.
